Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

In this piece, we will look at where Moderna, Inc. (NASDAQ:MRNA) sits on the fund managers’ radar. The surge in interest ...

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.

In an era where viral outbreaks can escalate into global pandemics with alarming speed, the ability to quickly develop new ...

Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

At IDWeek 2024, Moderna presented interim results from an ongoing Phase I/II dose-ranging trial for mRNA-1403, a vaccine ...